Lv4
724 积分 2022-10-31 加入
Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial
15天前
已完结
Toward immune tolerance in rheumatoid arthritis: Emerging immunotherapies and targets for long-term remission
15天前
已完结
Toll‐Like Receptor 8 is a Therapeutic Target in Rheumatoid Arthritis
15天前
已完结
Advances and challenges in Toll-like receptor-targeted therapy for rheumatoid arthritis
15天前
已完结
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial
15天前
已完结
CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis
15天前
已完结
OP0079 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-AND-TOCILIZUMAB CONTROLLED PHASE II TRIAL OF VDJ-001, A HIGH-AFFINITY IL-6R ANTAGONIST ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
15天前
已关闭
IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases
1个月前
已完结
The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey
1个月前
已完结
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups
1个月前
已完结
皖公网安备34019202002308
